Sitemap - 2021 - NPC Healthbiz Weekly
S06 E01 Rolling Out the Covid Vaccines: One Year Later
Reimagining pharma’s role in supporting healthcare professionals
National pharmacare won't solve lack of access
Making medication access more patient-centric
The challenge of attracting and balancing Pharma investment in Canada
Using employee resource groups to foster diversity and inclusion
Rethinking Pharma’s approach to DEI
Defining DEI: using terminology and metrics to lead by example
Next from NPC: The Congress continues
Next from NPC: 15th Annual Congress preview
How staying six feet apart brought us closer
Creating a culture of leadership
The Evolution of Pharma Leadership
Getting safely back to school (and elsewhere)
S05 E08 Combating Covid-19 Vaccine Hesitancy
Helping patients the vaccine can't protect
S05 E07 How Covid-19 Disrupted Cancer Patient Care
To serve and protect pharma production
S05 E06 Preventative Measures for the Pharmaceutical Production Line
Canada's pandemic-driven life sci strategy
S05 E05 The Post-Pandemic Life Sciences Landscape
Why medical cannabis should be covered by plans and payers: one doctor's view
S05 E04 The Emerging Role of Medical Cannabis
Funding life sciences development in Canada
S05 E03 The View From Bay Street: Life Sciences Investing in 2021
What makes us different, legally
S05 E02 Keeping It Legal: A Look at Life Sciences Laws and Regulations
How clinical trials are bringing breakthrough therapies to Canadian patients
S05 E01 Clinical Trials and CNS Research in Canada
Communicating health information to Canadian consumers
The post-Covid evolution of communication with external audiences
Building resilient healthcare systems in a post-crisis world
Pharma’s future in the post-Covid-19 world
The role of medical affairs in Pharma
S04 E08 Pharma's Future in the Post-Covid World
Bridging the gap between cancer research and patient care
S04 E07 The Role of Medical Affairs
The challenges of bringing rare disease therapies to Canada
S04 E06 Cancer Research and the Impact on Patient Care
Building a sustainable Life Sciences industry in Canada
S04 E05 Bringing Rare Disease Therapies into Canada
The pharma consultant’s role during Covid-19
S04 E04 Building a Sustainable Life Sciences Sector in Canada
Venture capital for the Life Sciences sector
S04 E03 Reflections on the Consultant's Role
Launching cancer treatments in Canada
S04 E02 Venture Capital for the Life Sciences
Covid-19’s effect on innovations in the Life Sciences industry
S04 E01 Bringing Anti-Cancer Therapies into Canada
Managing change and risks during Covid-19
Educating sales reps during Covid-19
Indigenous health during Covid-19
Covid-19’s impact on the med-tech sector
S03 E08 The Future of Life Sci Innovation in Canada
Keeping evidence current during Covid-19
S03 E07 Closing the Gap in Indigenous Health
Covid-19’s effect on Canada's health charities
S03 E06 Managing Change and Risk During Covid-19
Covid-19 and the opportunity for evolution in Pharma
S03 E05 The Future of Genomics and Life Sci in Canada
Covid-19’s influence on the government-LifeSci relationship
S03 E04 Switching From Pharma to Medtech
S03 E03 Keeping Evidence Current During Covid-19
Hurdles upon hurdles: How to launch a pharma product during Covid-19
Manufacturing priorities during a post-Covid launch
S03 E02 Education of Sales Reps During Covid-19
Leadership in a post-pandemic environment
S03 E01 Health Charities and the Impact of Covid-19
Managing a career in Pharma in the age of Covid-19